Navigation Links
VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis
Date:5/23/2011

SYDNEY, May 23, 2011 /PRNewswire/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced successful results of a major phase 2 clinical study that demonstrated efficacy of VivaGel(R) for the treatment of bacterial vaginosis (BV).

Key Points:

  • VivaGel(R) meets primary endpoint, demonstrating significant efficacy for treatment of BV
  • VivaGel(R) expected to avoid many shortcomings of existing therapies
  • Trial results support new patent filing which extends VivaGel(R) protection to at least 2032
  • Planning underway for Phase 3 trials for VivaGel(R) for BV treatment
  • BV prevention trial of VivaGel(R) to commence Q3 2011
  • Addressable global market for BV treatment and prevention potentially exceeds $1B

VivaGel(R) meets primary endpoint, demonstrating significant efficacy for treatment of BV

The study showed that treatment with VivaGel(R) (containing 1% of the active, SPL7013), once daily for seven days, resulted in 74% of patients achieving Clinical Cure of BV 2 to 5 days after completion of therapy compared with just 22% in the placebo group (P=0.0002).

Moreover, 2 to 3 weeks after completion of therapy, 46% of patients achieved Clinical Cure of BV compared with just 12% for the placebo (P=0.006) indicating that VivaGel(R) provided lasting cure in a significant proportion of the women. Both results were highly statistically significant and cure at both time points is considered by clinicians to be important in the clinical management of BV.

The main symptoms of BV are unpleasant vaginal discharge and odour. In Starpharma's study, vaginal BV discharge as assessed by the investigator was cured following treatment in 89% of the VivaGel(R) treated patients. Unpleasant vaginal odour was cured in 78% of the VivaGel(R) treated patients.

Dr Jackie Fairley, Chief Executive Officer of Starpharma, said: "Starpharma's objective is to d
'/>"/>

SOURCE Starpharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)...  Excite Medical was established by its President, ... Medical, under the leadership of Mr. Musallam , ... solid track record of providing unparalleled service and support ... Photo - http://photos.prnewswire.com/prnh/20150529/219412 ... possible, in large part, due to Mr. Musallam,s ...
(Date:5/29/2015)... 28, 2015 Research and Markets ( http://www.researchandmarkets.com/research/64lx2w/north_america_mri ... America MRI Market - Growth, Trends And Forecasts (2014 ... The North American MRI systems market is estimated to ... $1.58 billion by 2020 with a CAGR of 2.9% ... types namely, the open system, closed system and the ...
(Date:5/29/2015)... , May 29, 2015 A six-hour certification ... is being presented at the Cannabis World Congress & ... New York, NY .  Taking place on Wednesday, ... dedicated day of education at the leading event on the ... Led by Clover Leaf University, the first cannabis ...
Breaking Medicine Technology:North America MRI Market - Growth, Trends And Forecasts 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4
... Tyrima Demonstrates Good Safety Profile and Excellent,Pharmacokinetic Properties ... /PRNewswire/ --,CeNeRx BioPharma, Inc., a clinical stage company ... central,nervous system, today announced top-line results from a ... for the treatment,of depression and anxiety. In this ...
... /PRNewswire-FirstCall/ - Oncolytics,Biotech Inc. announced today ... reovirus in combination with gemcitabine is ... Cancer Research (AACR),website at <a target="_blank" ... at <a target="_blank" href=,"http://www.oncolyticsbiotech.com/">www.oncolyticsbiotech.com .,The abstract ...
Cached Medicine Technology:CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3Oncolytics Biotech Inc. Collaborators to Present,Reovirus/Gemcitabine Combination Research at AACR Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present,Reovirus/Gemcitabine Combination Research at AACR Annual Meeting 3
(Date:5/29/2015)... LAKE, CO (PRWEB) May 29, 2015 ... brand new addiction, substance abuse, and co-occurring mental ... celebration and ribbon cutting for the general public ... June 2nd. , The Recovery Village at Palmer ... and intensive outpatient programming, utilizing traditional and evidence-based ...
(Date:5/29/2015)... 29, 2015 On May 21, 2015, Elle ... When You Get Botox ?” reported on the four ... Elle partnered with Google to determine these results and then ... question in California, for example, is how to keep ... search query is what's the appropriate age to start receiving ...
(Date:5/29/2015)... 29, 2015 Johnson & Johnson ... confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement with ... to his use of the antipsychotic medication. According ... for the third bellwether trial to involve male ... underway in Pennsylvania’s Philadelphia Court of Common Pleas, ...
(Date:5/29/2015)... FL (PRWEB) May 29, 2015 ... Utah, recently partnered with Stratus Video ... which will facilitate better communication and timely ... (LEP) and hearing loss. Stratus’ video remote ... in-house translators, enabling staff to quickly access ...
(Date:5/29/2015)... Mediaplanet has joined forces with Colorescience ... Skin Health is a cross-platform campaign with a national ... New York, Los Angeles, and Chicago, the campaign is ... counterpart will reach a national audience through one of ... Skin Health campaign and Colorescience, click here . ...
Breaking Medicine News(10 mins):Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2
... indelible impact on the lives of many in 2004 and ... ,The most recent data enabled by the AMA ... to CVD, at 406 deaths per 100,000 people. Minnesota portrayed ... 100,000 people. ,The statistics also pointed out ...
... A comprehensive review published in the January 1st issue ... diseases// characterized by selective cell loss, narcolepsy may be ... in genetically susceptible individuals - a possible contradiction to ... responses and stressful life events are factors that may ...
... 60-year-old woman has brought about a revolution in the lives ... determined retiree from Hong Kong, decided one day to live ... there. That momentous decision has made a huge difference to ... is the only nurse at the Tanshan Leper Rehabilitation Village ...
... Chandigarh: Children, pregnant and lactating women and adolescent ... from the state government for their nutritional needs. ... Monday announced enhanced quantum for supplementary nutritional needs ... Development Service (ICDS) scheme. ,She said ...
... down on calories could help in preventing or delaying ... University of Alabama at Birmingham suggest that a key ... body composition (being lean or obese) and whether calories ... the risk of cancer., ,During a study conducted ...
... your New Year resolutions, The Alliance for Aging Research// has ... both physical as well as mental exercise to stay fighting ... Alliance for Aging Research said, "There is a lot we ... or lessen the cognitive decline that often comes with aging. ...
Cached Medicine News:Health News:Narcolepsy May Be Caused By Environmental Exposures: Study 2Health News:A ‘Good Samaritan’ to the Aid of Lepe 2Health News:A ‘Good Samaritan’ to the Aid of Lepe 3
...
... features an advanced design that accommodates both ... gives surgeons the flexibility to easily customize ... is built-in to every aspect of the ... Secure-Twist anti-migration system to the screw options ...
... is designed to meet the clinical challenges ... attached locking mechanism and the choice of ... variable angle screws for ease of implantation ... plate system allows the surgeon the versatility ...
... Revolutions start with small things. ... is one of the trailblazers of ... reflecting the,trend towards ever smaller access ... the operation site. ,The HiLAN XS ...
Medicine Products: